Elevance HealthELV
紐約證券 · USD
360.22
+19.18
(+5.62%)
收盤 12/12 05:00 (UTC+8)
盤後
356.10
356.10
(-1.14%)
12/12 05:00 (UTC+8)
Elevance HealthELV
360.22
+19.18
(+5.62%)
財務數據
損益表
- 436.72
- 428.49
- 426.47
- 425.77
- 436.46
- 451.45
- 454.42
- 488.91
- 497.76
- 507.11
- 3.56
- -1.88
- -0.47
- -0.16
- 2.51
- 3.43
- 0.66
- 7.59
- 1.81
- 1.88
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | 50,711,000 | 49,776,000 | 48,891,000 | 45,442,000 | 45,145,000 | 43,646,000 | 42,577,000 | 42,647,000 | 42,849,000 | 43,672,000 |
營業成本 | 38,140,000 | 36,706,000 | 35,312,000 | 33,500,000 | 32,949,000 | 30,572,000 | 30,546,000 | 31,334,000 | 30,606,000 | 31,604,000 |
營業毛利 | 12,571,000 | 13,070,000 | 13,579,000 | 11,942,000 | 12,196,000 | 13,074,000 | 12,031,000 | 11,313,000 | 12,243,000 | 12,068,000 |
營業費用 | 10,814,000 | 10,437,000 | - | 10,996,000 | - | - | 8,827,000 | 10,053,000 | 10,330,000 | 9,366,000 |
研發費用 | - | - | - | - | - | - | - | - | - | - |
推銷及管理費用 | - | - | - | - | - | - | - | - | - | - |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | 10,814,000 | 10,437,000 | 10,438,000 | 10,996,000 | 10,484,000 | 10,048,000 | 8,827,000 | 10,053,000 | 10,330,000 | 9,366,000 |
營業利益 | 1,406,000 | 2,292,000 | 2,797,000 | 606,000 | 1,412,000 | 2,746,000 | 2,939,000 | 1,001,000 | 1,654,000 | 2,441,000 |
其他收入及費用 | - | - | - | - | -39,000 | 240,000 | - | - | - | - |
利息費用 | 351,000 | 341,000 | 344,000 | 340,000 | 300,000 | 280,000 | 265,000 | 259,000 | 259,000 | 261,000 |
稅前純益 | 1,406,000 | 2,292,000 | 2,797,000 | 606,000 | 1,373,000 | 2,986,000 | 2,939,000 | 1,001,000 | 1,654,000 | 2,441,000 |
所得稅 | 219,000 | 548,000 | 613,000 | 193,000 | 365,000 | 685,000 | 690,000 | 170,000 | 354,000 | 585,000 |
稅後純益 | 1,189,000 | 1,743,000 | 2,183,000 | 418,000 | 1,016,000 | 2,300,000 | 2,246,000 | 856,000 | 1,289,000 | 1,853,000 |
基本每股稅後盈餘(元) | 5.36 | 7.75 | 9.67 | 1.84 | 4.38 | 9.92 | 9.65 | 3.67 | 5.48 | 7.86 |
稀釋每股稅後盈餘(元) | 5.34 | 7.72 | 9.61 | 1.87 | 4.37 | 9.85 | 9.59 | 3.66 | 5.46 | 7.80 |
基本平均股數(千股) | 222036.00 | 224835.00 | 225641.00 | 227479.00 | 231929.00 | 231902.00 | 232700.00 | 233071.00 | 235300.00 | 235861.00 |
稀釋平均股數(千股) | 223700.00 | 225800.00 | 227159.00 | 231100.00 | 233100.00 | 233400.00 | 234200.00 | 235800.00 | 236500.00 | 237800.00 |
還原基本每股稅後盈餘(元) | 5.36 | 7.75 | 9.67 | 1.84 | 4.38 | 9.92 | 9.65 | 3.67 | 5.48 | 7.86 |
還原稀釋每股稅後盈餘(元) | 5.34 | 7.72 | 9.61 | 1.87 | 4.37 | 9.85 | 9.59 | 3.66 | 5.46 | 7.80 |
還原基本平均股數(千股) | 222,036 | 224,835 | 225,641 | 227,479 | 231,929 | 231,902 | 232,700 | 233,071 | 235,300 | 235,861 |
還原稀釋平均股數(千股) | 223,700 | 225,800 | 227,159 | 231,100 | 233,100 | 233,400 | 234,200 | 235,800 | 236,500 | 237,800 |
EBITDA(千元) | 2,146,000 | 3,012,000 | 3,513,000 | 1,349,000 | 2,010,000 | 3,600,000 | 3,532,000 | 1,709,000 | 2,328,000 | 3,132,000 |